Tuesday, March 29, 2022 9:22:40 AM
LIVE-AIR Results featured on the cover. The Lancet Respiratory Medicine, March 2022, Volume 10, Issue 3, Pages 221-312, e25-e33 #lenzilumab https://t.co/b8vzZIu2Vf
— Humanigen, Inc. (@humanigen) March 29, 2022
LIVE-AIR Results featured on the cover. The Lancet Respiratory Medicine, March 2022, Volume 10, Issue 3, Pages 221-312, e25-e33
https://www.thelancet.com/journals/lanres/issue/vol10no3/PIIS2213-2600(22)X0003-9
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
